REG - Cerillion PLC - Director/PDMR Shareholding

CerillionAnnouncement

Today 08:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251023:nRSW4240Ea&default-theme=true

RNS Number : 4240E  Cerillion PLC  23 October 2025

AIM: CER

Cerillion plc

("Cerillion" or the "Company")

PDMR shareholding

 

Cerillion, the billing, charging and customer relationship management software
solutions provider, announces that in accordance with notification obligations
under article 19.3 of the Market Abuse Regulation, that on 23 October 2025
Affinity Trust Limited, a trust established for the benefit of Louis Hall,
CEO, transferred at nil cost the beneficial interest in 3,346,887 ordinary
shares of 0.5 pence each in the Company ("Ordinary Shares") to Louis Hall.
Louis Hall's beneficial interest remains unchanged.

The information below is set out in accordance with the requirements of the
Market Abuse Regulation (EU) 596/2014 (which forms part of UK domestic law
pursuant to the European Union (Withdrawal) Act 2018, as amended),

 

Enquiries:

 Cerillion plc                                                  c/o KTZ Communications
 Louis Hall, CEO                                                T: 020 3178 6378
 Andrew Dickson, CFO
 Panmure Liberum Limited (Nomad and Joint Broker)               T: 020 3100 2000
 Bidhi Bhoma, Edward Mansfield, Shalin Bhamra, Freddie Wooding
 Singer Capital Markets (Joint Broker)                          T: 020 7496 3000
 Rick Thompson, James Fischer
 KTZ Communications                                             T: 020 3178 6378
 Katie Tzouliadis, Robert Morton

 

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Affinity Trust Limited

 2    Reason for the notification

 a)   Position/status                                              PCA of PDMR of Louis Hall, CEO and PDMR

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Cerillion PLC

 b)   LEI                                                          213800ISIZMUC3P46850

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted
 a)   Description of the financial instrument, type of instrument  Ordinary shares of GBP 0.005 each

        Identification code                                        GB00BYYX6C66

 b)   Nature of the transaction                                    Sale of Ordinary Shares

 c)   Price(s) and volume(s)                                         Price(s) (£)     Volume(s)

                                                            0         3,346,887

 
 d)   Aggregated information

         - Aggregated volume                                       3,346,887 Ordinary Shares

       - Price                                                     £0

 e)   Date of the transaction                                      23 October 2025

 f)   Place of the transaction                                     Outside of a trading venue

 

d)

 

Aggregated information

   - Aggregated volume

 - Price

 

3,346,887 Ordinary Shares

£0

 

e)

 

Date of the transaction

23 October 2025

f)

 

Place of the transaction

 

Outside of a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHEAFEAAENSFFA



            Copyright 2019 Regulatory News Service, all rights reserved